Skip to main content
PMC home page
RNA logoLink to RNA
. 2001 May;7(5):710–721. doi: 10.1017/s1355838201010111

Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame.

J L Walewski 1, T R Keller 1, D D Stump 1, A D Branch 1
PMCID: PMC1370123  PMID: 11350035

Abstract

Many viruses have overlapping genes and/or regions in which a nucleic acid signal is embedded in a coding sequence. To search for dual-use regions in the hepatitis C virus (HCV), we developed a facile computer-based sequence analysis method to map dual-use regions in coding sequences. Eight diverse full-length HCV RNA and polyprotein sequences were aligned and analyzed. A cluster of unusually conserved synonymous codons was found in the core-encoding region, indicating a potential overlapping open reading frame (ORF). Four peptides (A1, A2, A3, and A4) representing this alternate reading frame protein (ARFP), two others from the HCV core protein, and one from bovine serum albumin (BSA) were conjugated to BSA and used in western blots to test sera for specific antibodies from 100 chronic HCV patients, 44 healthy controls, and 60 patients with non-HCV liver disease. At a 1:20,000 dilution, specific IgGs to three of the four ARFP peptides were detected in chronic HCV sera. Reactivity to either the A1 or A3 peptides (both ARFP derived) was significantly associated with chronic HCV infection, when compared to non-HCV liver disease serum samples (10/100 versus 1/60; p < 0.025). Antibodies to A4 were not detected in any serum sample. Our western blot assays confirmed the presence of specific antibodies to a new HCV antigen encoded, at least in part, in an alternate reading frame (ARF) overlapping the core-encoding region. Because this novel HCV protein stimulates specific immune responses, it has potential value in diagnostic tests and as a component of vaccines. This protein is predicted to be highly basic and may play a role in HCV replication, pathogenesis, and carcinogenesis.

Full Text

The Full Text of this article is available as a PDF (691.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beard M. R., Abell G., Honda M., Carroll A., Gartland M., Clarke B., Suzuki K., Lanford R., Sangar D. V., Lemon S. M. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology. 1999 Jul;30(1):316–324. doi: 10.1002/hep.510300137. [DOI] [PubMed] [Google Scholar]
  2. Brierley I. Ribosomal frameshifting viral RNAs. J Gen Virol. 1995 Aug;76(Pt 8):1885–1892. doi: 10.1099/0022-1317-76-8-1885. [DOI] [PubMed] [Google Scholar]
  3. Brown E. A., Zhang H., Ping L. H., Lemon S. M. Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res. 1992 Oct 11;20(19):5041–5045. doi: 10.1093/nar/20.19.5041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bullock T. N., Eisenlohr L. C. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J Exp Med. 1996 Oct 1;184(4):1319–1329. doi: 10.1084/jem.184.4.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Caramelo C., Bartolomé J., Albalate M., de Sequera P., Navas S., Bermejillo T., Oliva H., Marriott E., Ortiz A., Ruiz Tuñn C. Undiagnosed hepatitis C virus infection in hemodialysis patients: value of HCV RNA and liver enzyme levels. Kidney Int. 1996 Dec;50(6):2027–2031. doi: 10.1038/ki.1996.525. [DOI] [PubMed] [Google Scholar]
  6. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  7. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  8. Feucht H. H., Zöllner B., Polywka S., Laufs R. Study on reliability of commercially available hepatitis C virus antibody tests. J Clin Microbiol. 1995 Mar;33(3):620–624. doi: 10.1128/jcm.33.3.620-624.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Higashi Y., Kakumu S., Yoshioka K., Wakita T., Mizokami M., Ohba K., Ito Y., Ishikawa T., Takayanagi M., Nagai Y. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology. 1993 Dec;197(2):659–668. doi: 10.1006/viro.1993.1641. [DOI] [PubMed] [Google Scholar]
  10. Honda M., Ping L. H., Rijnbrand R. C., Amphlett E., Clarke B., Rowlands D., Lemon S. M. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology. 1996 Aug 1;222(1):31–42. doi: 10.1006/viro.1996.0395. [DOI] [PubMed] [Google Scholar]
  11. Honda M., Rijnbrand R., Abell G., Kim D., Lemon S. M. Natural variation in translational activities of the 5' nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site. J Virol. 1999 Jun;73(6):4941–4951. doi: 10.1128/jvi.73.6.4941-4951.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Huber K. R., Sebesta C., Bauer K. Detection of common hepatitis C virus subtypes with a third-generation enzyme immunoassay. Hepatology. 1996 Sep;24(3):471–473. doi: 10.1002/hep.510240301. [DOI] [PubMed] [Google Scholar]
  13. Ina Y., Mizokami M., Ohba K., Gojobori T. Reduction of synonymous substitutions in the core protein gene of hepatitis C virus. J Mol Evol. 1994 Jan;38(1):50–56. doi: 10.1007/BF00175495. [DOI] [PubMed] [Google Scholar]
  14. Kolykhalov A. A., Agapov E. V., Blight K. J., Mihalik K., Feinstone S. M., Rice C. M. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science. 1997 Jul 25;277(5325):570–574. doi: 10.1126/science.277.5325.570. [DOI] [PubMed] [Google Scholar]
  15. Kotwal G. J., Baroudy B. M., Kuramoto I. K., McDonald F. F., Schiff G. M., Holland P. V., Zeldis J. B. Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4486–4489. doi: 10.1073/pnas.89.10.4486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  17. Liston P., Briedis D. J. Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein. J Virol. 1995 Nov;69(11):6742–6750. doi: 10.1128/jvi.69.11.6742-6750.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lu H. H., Wimmer E. Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1412–1417. doi: 10.1073/pnas.93.4.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Malarkannan S., Horng T., Shih P. P., Schwab S., Shastri N. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity. 1999 Jun;10(6):681–690. doi: 10.1016/s1074-7613(00)80067-9. [DOI] [PubMed] [Google Scholar]
  20. Martell M., Esteban J. I., Quer J., Genescà J., Weiner A., Esteban R., Guardia J., Gómez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 1992 May;66(5):3225–3229. doi: 10.1128/jvi.66.5.3225-3229.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moazed D., Noller H. F. Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature. 1987 Jun 4;327(6121):389–394. doi: 10.1038/327389a0. [DOI] [PubMed] [Google Scholar]
  22. Reynolds J. E., Kaminski A., Kettinen H. J., Grace K., Clarke B. E., Carroll A. R., Rowlands D. J., Jackson R. J. Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J. 1995 Dec 1;14(23):6010–6020. doi: 10.1002/j.1460-2075.1995.tb00289.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rüster B., Zeuzem S., Roth W. K. Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem Biophys Res Commun. 1996 Feb 27;219(3):911–915. doi: 10.1006/bbrc.1996.0340. [DOI] [PubMed] [Google Scholar]
  24. Sanger F., Air G. M., Barrell B. G., Brown N. L., Coulson A. R., Fiddes C. A., Hutchison C. A., Slocombe P. M., Smith M. Nucleotide sequence of bacteriophage phi X174 DNA. Nature. 1977 Feb 24;265(5596):687–695. doi: 10.1038/265687a0. [DOI] [PubMed] [Google Scholar]
  25. Seelig R., Renz M., Bottner C., Seelig H. P. Hepatitis C virus infections in dialysis units: prevalence of HCV-RNA and antibodies to HCV. Ann Med. 1994 Feb;26(1):45–52. doi: 10.3109/07853899409147326. [DOI] [PubMed] [Google Scholar]
  26. Smith D. B., Simmonds P. Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol. 1997 Sep;45(3):238–246. doi: 10.1007/pl00006226. [DOI] [PubMed] [Google Scholar]
  27. Sällberg M., Rudén U., Wahren B., Magnius L. O. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J Clin Microbiol. 1992 Aug;30(8):1989–1994. doi: 10.1128/jcm.30.8.1989-1994.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Takaki A., Wiese M., Maertens G., Depla E., Seifert U., Liebetrau A., Miller J. L., Manns M. P., Rehermann B. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000 May;6(5):578–582. doi: 10.1038/75063. [DOI] [PubMed] [Google Scholar]
  29. Tam A. W., Smith M. M., Guerra M. E., Huang C. C., Bradley D. W., Fry K. E., Reyes G. R. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991 Nov;185(1):120–131. doi: 10.1016/0042-6822(91)90760-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tsukiyama-Kohara K., Iizuka N., Kohara M., Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol. 1992 Mar;66(3):1476–1483. doi: 10.1128/jvi.66.3.1476-1483.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yanagi M., Purcell R. H., Emerson S. U., Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8738–8743. doi: 10.1073/pnas.94.16.8738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yeh C. T., Lu S. C., Chu C. M., Liaw Y. F. Molecular cloning of a defective hepatitis C virus genome from the ascitic fluid of a patient with hepatocellular carcinoma. J Gen Virol. 1997 Nov;78(Pt 11):2761–2770. doi: 10.1099/0022-1317-78-11-2761. [DOI] [PubMed] [Google Scholar]

Articles from RNA are provided here courtesy of The RNA Society

RESOURCES